Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Phenomenon Secondary to Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00707187
What this trial is testing

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Who this might be right for
Systemic Sclerosis
University of Medicine and Dentistry of New Jersey 120
Large-scale testing (Phase 3)Study completedNCT00253331
What this trial is testing

Lab Study of MQX-503 in Treatment of Raynaud's

Who this might be right for
Raynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease
MediQuest Therapeutics 36
Not applicableStudy completedNCT01072669
What this trial is testing

Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet

Who this might be right for
Ischemia
Soumya Chatterjee 20
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Testing effectiveness (Phase 2)Study completedNCT00378521
What this trial is testing

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
MediQuest Therapeutics 15
Large-scale testing (Phase 3)Study completedNCT00004786
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud Disease
National Center for Research Resources (NCRR) 200
Not applicableStudy completedNCT00946738
What this trial is testing

The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's PhenomenonSystemic Sclerosis
Charite University, Berlin, Germany 28
Testing effectiveness (Phase 2)Study completedNCT00480753
What this trial is testing

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 15